LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

Search

Phibro Animal Health Corp

Fechado

SetorSaúde

40.45 2.04

Visão Geral

Variação de preço das ações

24h

Atual

Mín

39.1

Máximo

41.4

Indicadores-chave

By Trading Economics

Rendimento

9.3M

27M

Vendas

-15M

364M

P/E

Médio do Setor

24

77.671

EPS

0.73

Rendimento de Dividendos

1.23

Margem de lucro

7.29

Funcionários

2,475

EBITDA

22M

63M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+19.14% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

1.23%

2.35%

Próxima data de dividendos

17 de dez. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-133M

1.6B

Abertura anterior

38.41

Fecho anterior

40.45

Sentimento de Notícias

By Acuity

20%

80%

53 / 374 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Strong Bullish Evidence

Phibro Animal Health Corp Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

10 de dez. de 2025, 22:02 UTC

Ganhos

Synopsys Sees Strong 2026 as Ansys Acquisition Boosts 4Q Revenue

10 de dez. de 2025, 21:46 UTC

Ganhos

Adobe Expects Double-Digit Recurring Revenue Growth Next Year

10 de dez. de 2025, 23:52 UTC

Aquisições, Fusões, Aquisições de Empresas

Paramount Sends Letter to Warner Bros. Shareholders Saying Its Offer Is 'Superior' -- Barrons.com

10 de dez. de 2025, 23:43 UTC

Conversa de Mercado

Nikkei May Rise After Fed Rate Cut -- Market Talk

10 de dez. de 2025, 23:36 UTC

Conversa de Mercado

Gold Consolidates as Traders Digest FOMC Decision -- Market Talk

10 de dez. de 2025, 23:20 UTC

Ganhos

Oracle Reports $16.1 Billion in Revenue, Narrowly Missing Forecasts -- 2nd Update

10 de dez. de 2025, 23:15 UTC

Ganhos

Synopsys Targets Double-Digit Growth Following Ansys Acquisition -- Interview

10 de dez. de 2025, 22:59 UTC

Conversa de Mercado
Ganhos
Aquisições, Fusões, Aquisições de Empresas

Adobe Expects Semrush Deal to Bring in New Users -- Market Talk

10 de dez. de 2025, 22:45 UTC

Conversa de Mercado

Coca-Cola's New CEO Pick Looks A Lot Like The Last One -- Market Talk

10 de dez. de 2025, 22:40 UTC

Ganhos

Synopsys Stock Rises on Earnings Beat, Higher Guidance -- Barrons.com

10 de dez. de 2025, 22:06 UTC

Aquisições, Fusões, Aquisições de Empresas

Paramount Sends Letter to Warner Bros. Shareholders Saying Their Offer Is 'Superior' -- Barrons.com

10 de dez. de 2025, 22:06 UTC

Ganhos

Oracle Reports Mixed Earnings. The Stock Is Falling. -- Barrons.com

10 de dez. de 2025, 22:02 UTC

Ganhos

Synopsys Stock Rises on Earnings Beat, Higher Guidance -- Barrons.com

10 de dez. de 2025, 22:00 UTC

Ganhos

Oracle Reports $16.1 Billion in Revenue, Narrowly Missing Forecasts -- Update

10 de dez. de 2025, 21:53 UTC

Ganhos

Adobe Earnings Show 'Rapid Adoption' of AI Tools. The Stock Is Up. -- Barrons.com

10 de dez. de 2025, 21:50 UTC

Aquisições, Fusões, Aquisições de Empresas

Investors Bet That a Higher Bid for Warner Is Coming -- Update

10 de dez. de 2025, 21:50 UTC

Conversa de Mercado
Ganhos
Aquisições, Fusões, Aquisições de Empresas

Financial Services Roundup: Market Talk

10 de dez. de 2025, 21:50 UTC

Conversa de Mercado

Health Care Roundup: Market Talk

10 de dez. de 2025, 21:50 UTC

Conversa de Mercado

Auto & Transport Roundup: Market Talk

10 de dez. de 2025, 21:45 UTC

Aquisições, Fusões, Aquisições de Empresas

Paramount Sends Letter to Warner Bros. Shareholders Saying Their Offer Is 'Superior' -- Barrons.com

10 de dez. de 2025, 21:33 UTC

Ganhos

Oracle Reports $16.1 Billion in Revenue, Narrowly Missing Forecasts -- WSJ

10 de dez. de 2025, 21:32 UTC

Ganhos

Oracle Reports Mixed Earnings. The Stock Is Falling. -- Barrons.com

10 de dez. de 2025, 21:28 UTC

Aquisições, Fusões, Aquisições de Empresas

Sverica Capital Management Announces Sale of Coastal Cloud Holdings to Tata Consultancy Services for $700M

10 de dez. de 2025, 21:25 UTC

Ganhos

Adobe Earnings Show 'Rapid Adoption' of AI Tools. The Stock Is Up. -- Barrons.com

10 de dez. de 2025, 21:18 UTC

Aquisições, Fusões, Aquisições de Empresas

Paramount Skydance: Company Has Air Tight Financing to Deliver on Warner Bros. Offer >PSKY

10 de dez. de 2025, 21:16 UTC

Ganhos

Oracle Reports Mixed Earnings. The Stock is Falling. -- Barrons.com

10 de dez. de 2025, 21:15 UTC

Aquisições, Fusões, Aquisições de Empresas

Paramount Skydance: Public Offer for Warner Bros. Delivers Superior Value, Faster, More Certain Path to Completion

10 de dez. de 2025, 21:15 UTC

Ganhos

Oracle: 'Sold Ampere Because We No Longer Think It Is Strategic for Us to Continue Designing, Manufacturing and Using Our Own Chips in Our Cloud Datacenters' >ORCL

10 de dez. de 2025, 21:14 UTC

Ganhos

Oracle 2Q Non-GAAP Operating Income Was $6.7 B >ORCL

10 de dez. de 2025, 21:14 UTC

Ganhos

Oracle 2Q GAAP Operating Income Was $4.7 B >ORCL

Comparação entre Pares

Variação de preço

Phibro Animal Health Corp Previsão

Preço-alvo

By TipRanks

19.14% parte superior

Previsão para 12 meses

Média 47.5 USD  19.14%

Máximo 50 USD

Mínimo 45 USD

Com base em 2 analistas de Wall Street que oferecem metas de preço de 12 meses para Phibro Animal Health Corp - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

2 ratings

1

Comprar

1

Manter

0

Vender

Pontuação Técnica

By Trading Central

17 / N/ASuporte e Resistência

Curto Prazo

Strong Bullish Evidence

Médio Prazo

Weak Bearish Evidence

Longo Prazo

Weak Bearish Evidence

Sentimento

By Acuity

53 / 374 Ranking em Saúde

Sentimento de Notícias

Evidência Muito Forte de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Phibro Animal Health Corp

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in development, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey.
help-icon Live chat